martes, 28 de abril de 2026
Rewriting the Genetic Code: Designing Biologics with Noncanonical Amino Acids avatar David Alvaro, Ph.D. Editor in Chief April Stanley, MS MBA Senior Scientific Research Director and M&A Advisor Nice Insight
Rewriting the Genetic Code: Designing Biologics with Noncanonical Amino Acids
David Alvaro, Ph.D.
Editor in Chief
April Stanley, MS MBA
Senior Scientific Research Director and M&A Advisor
Nice Insight
https://www.pharmasalmanac.com/articles/rewriting-the-genetic-code-designing-biologics-with-noncanonical-amino-acids
Advances in genetic code expansion are enabling the incorporation of noncanonical amino acids into proteins, expanding the chemical capabilities of biologics and opening new possibilities for designing therapeutic proteins with precisely engineered functions.
Suscribirse a:
Enviar comentarios (Atom)


No hay comentarios:
Publicar un comentario